Carmell Therapeutics Corporation (CTCX) Insider Trading
Total insider buys:
- $106,471.98
Total insider sells:
- $0.00
Most recent insider trade:
- Sept. 10, 2024
Most active insider trader:
- Rajiv Shukla
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 10, 2024 | CFO | 475 | $0.46 | Buy | $218.50 | |
| Sept. 6, 2024 | Director | 1,260 | $0.51 | Buy | $642.60 | |
| Aug. 30, 2024 | Director | 87 | $0.57 | Buy | $49.59 | |
| Aug. 29, 2024 | CFO | 1,000 | $0.57 | Buy | $570.00 | |
| Aug. 28, 2024 | Director | 970 | $0.56 | Buy | $543.20 | |
| Aug. 26, 2024 | Director | 1,587 | $0.72 | Buy | $1,142.64 | |
| Aug. 22, 2024 | Director | 2,413 | $0.72 | Buy | $1,737.36 | |
| Aug. 20, 2024 | Director | 3,600 | $0.89 | Buy | $3,204.00 | |
| June 12, 2024 | Director | 2,000 | $2.20 | Buy | $4,400.00 | |
| June 10, 2024 | CFO | 440 | $2.50 | Buy | $1,100.00 | |
| June 6, 2024 | CEO | 2,100 | $2.63 | Buy | $5,523.00 | |
| May 29, 2024 | CFO | 30 | $2.60 | Buy | $78.00 | |
| May 24, 2024 | CEO | 1,939 | $2.57 | Buy | $4,983.23 | |
| May 22, 2024 | CEO | 4,051 | $2.41 | Buy | $9,762.91 | |
| May 20, 2024 | CEO | 1,172 | $2.22 | Buy | $2,601.84 | |
| Dec. 14, 2023 | Director | 313 | $3.61 | Buy | $1,129.93 | |
| Dec. 12, 2023 | Director | 2,000 | $3.50 | Buy | $7,000.00 | |
| Dec. 7, 2023 | Director | 199 | $3.07 | Buy | $610.93 | |
| Dec. 5, 2023 | Director | 277 | $3.10 | Buy | $858.70 | |
| Nov. 30, 2023 | CEO | 5,600 | $2.66 | Buy | $14,896.00 | |
| Nov. 28, 2023 | CFO | 1,500 | $2.85 | Buy | $4,275.00 | |
| Nov. 27, 2023 | CEO | 2,100 | $2.97 | Buy | $6,237.00 | |
| Nov. 24, 2023 | CEO | 2,715 | $2.95 | Buy | $8,009.25 | |
| Nov. 22, 2023 | CEO | 1,185 | $2.78 | Buy | $3,294.30 | |
| Nov. 20, 2023 | CEO | 3,750 | $2.62 | Buy | $9,825.00 | |
| Nov. 17, 2023 | CEO | 2,000 | $2.69 | Buy | $5,380.00 | |
| Aug. 28, 2023 | CEO | 100 | $3.49 | Buy | $349.00 | |
| Aug. 28, 2023 | Chairman | 2,100 | $3.50 | Buy | $7,350.00 | |
| Aug. 25, 2023 | CEO | 200 | $3.50 | Buy | $700.00 |
First«1 of 1»Last
Insiders are buying Carmell Therapeutics Corporation stock.
The insider traders at Carmell Therapeutics Corporation are: Rajiv Shukla, Bryan J Cassaday, Richard A Upton, Scott M Frisch, Kathryn Gregory, Patrick A Sturgeon, Randolph W Hubbell, and Gilles Spenlehauer
The most active insider trader at Carmell Therapeutics Corporation is Rajiv Shukla with 11 trades.
Rajiv Shukla has bought the most Carmell Therapeutics Corporation stock with a total value of $83,385.53.
The most recent insider trade for Carmell Therapeutics Corporation was on Sept. 10, 2024.
The single biggest insider buy for Carmell Therapeutics Corporation was from Rajiv Shukla with a total value of $14,896.00 on Nov. 30, 2023.